Navigation Links
SPO Updates Shareholders on 2012 Corporate Strategy
Date:1/24/2012

NEW YORK, January 24, 2012 /PRNewswire/ --

SPO Medical Inc. (SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced today an update to its shareholders on the Company's product and revenue generation strategy for fiscal 2012 primarily based on the completion of development and launch of a new range of consumer wellness devices.

SPO currently has three products in development stage which utilize the Company's proprietary intellectual property portfolio. SPO anticipates revenue generation via a recently contracted strategic distribution partner for its consumer wellness bracelet to commence during the second half of 2012.

The products under development are:

(i) A new and unique consumer wellness bracelet designed to measure a person's overall daily activity level, especially useful for the overweight or obese. The wellness bracelet, both for children and adults, contains  innovative features including display functionality and a time-piece which continuously measures the number of daily activities and calories burned against a recommended goal.

(ii) A sports and wellness wristwatch using SPO' vital sign technology for continuous heart rate measurement, which negates the need for the traditional chest-strap currently being used by most sports watch manufacturers. The ability to accurately and reliably measure heart-rate from the wrist area during motion has been a major challenge for the sports watch industry which typically required a chest-strap for acquiring continuous heart-rate readings.

(iii) An innovative home-baby monitoring device for continuous measurement of wellness information to the parent or caregiver, while the baby is sleeping. This parental reassurance tool gives the company a technological competitive edge in providing an innovative, high performance solution for a market application t
'/>"/>

SOURCE SPO Medical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Anadys Pharmaceuticals Updates Its Presentation Date at the Stifel Nicolaus Healthcare Conference
2. Auxilium Pharmaceuticals, Inc. Updates Launch Progress of XIAPEX® in EU
3. Bacterin International Updates Fourth Quarter and Full Year 2010 Financial Results
4. Warner Chilcott Successfully Completes Refinancing of Senior Secured Credit Facilities and Updates Full Year 2011 Financial Guidance
5. Dendreon to Host Conference Call to Provide Updates on U.S. Commercialization Progress, European Strategy for PROVENGE, and Pipeline Progress
6. Vista Partners Updates Coverage on Opexa Therapeutics, Inc.; Raises Target Price From $4.40 to $6.50
7. Cardium Reports Excellagen Matrix Clinical Study Results Accepted for Publication by Peer-Reviewed Journal, and Updates Product Plans
8. NEURO-BIOTECH CORPORATION: Updates and latest developments
9. China Cord Blood Corporation Updates Status Regarding Share Repurchase Program
10. Cord Blood America CEO Updates Investors on Financial Developments and Stem Cell News in Interview
11. China-Biotics Provides Further Updates on Qingpu New Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... rather than electricity, to move data would consume ... a growing concern as chips, transistor counts rise. ... circuits light emitters, modulators, and detectors ... light source for optical chips is molybdenum disulfide ... as a single, atom-thick layer. Other experimental on-chip ...
(Date:9/19/2014)... , September 19, 2014 ... technology, development of emerging drug systems and advanced Laboratory ... Dickinson and Company (NYSE: BDX ), Thermo ... Biosciences Inc. (NASDAQ: RGDO ), Sangamo Biosciences ... (NASDAQ: HOLX) Pressure BioSciences, Inc. (OTCQB: PBIO) ...
(Date:9/19/2014)... CORAL SPRINGS, Florida , September 19, 2014 /PRNewswire/ ... biotech companies release latest developments, patents and results of ... (OTC: GNSZ), Eli Lilly and Company (NYSE: ... ), Celgene Corporation (NASDAQ: CELG ) and ... (OTCQB: GNSZ), a leader in developing prodrug therapeutics for ...
(Date:9/19/2014)... , September 19, 2014 ... and Markets ( http://www.researchandmarkets.com/research/b2jxhs/micro_market ) has announced the addition ... Chromatography Columns"  report to their offering.  ... market is one of the fastest-growing segments in ... $1.2 billion in 2013, and expected to reach ...
Breaking Biology Technology:Toward optical chips 2Toward optical chips 3Medical Instrumentation Automation Advances for Biological Sample Preparation - Company Expects Q4 Revenue Impact from Newest Instrument Systems 2Medical Instrumentation Automation Advances for Biological Sample Preparation - Company Expects Q4 Revenue Impact from Newest Instrument Systems 3Medical Instrumentation Automation Advances for Biological Sample Preparation - Company Expects Q4 Revenue Impact from Newest Instrument Systems 4Medical Instrumentation Automation Advances for Biological Sample Preparation - Company Expects Q4 Revenue Impact from Newest Instrument Systems 5Medical Instrumentation Automation Advances for Biological Sample Preparation - Company Expects Q4 Revenue Impact from Newest Instrument Systems 6Medical Instrumentation Automation Advances for Biological Sample Preparation - Company Expects Q4 Revenue Impact from Newest Instrument Systems 7Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 2Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 3Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 4Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 5Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 6Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 7Micro Market Monitor : Global Pre-packed Chromatography Columns 2
... economic,and business growth in the Tampa Bay Region from the ... Acquires Manufacturing Site in Tampa Bay , ... St. Petersburg recently where it plans to manufacture microchips for ... should be completed,in March 2009. The site could employ ...
... PRINCETON, N.J., Jan. 6 Medarex, Inc. (Nasdaq: ... at the 27th Annual J.P. Morgan Healthcare Conference at 8:30 ... 13, 2009. The event will be webcast live and will ... website at www.medarex.com . An archived edition of the ...
... Biosciences, Inc. announced today that David J. Mazzo, Ph.D., ... the 27th Annual J.P. Morgan Healthcare Conference in San ... Pacific Time (2:30pm Eastern Time). Dr. Mazzo,s presentation ... in development, the REG1 System, its pipeline and enterprise-level ...
Cached Biology Technology:Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs) 2Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs) 3Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs) 4Medarex to Present at the 27th Annual J.P. Morgan Healthcare Conference 2
(Date:9/18/2014)... new GSA Bulletin study uses tree rings ... and Chaco Wash in northern New Mexico, USA. By ... and willow, investigators were able to precisely date arroyo ... combined this data with aerial imagery, LiDAR, longitudinal profiles, ... arroyos. , Arroyos are deep, oversized channels that have ...
(Date:9/18/2014)... researchers from McGill University and the Quebec government ... ,microbeads, Canadian Journal of Fisheries and Aquatic ... cosmetics, household cleansers, or industrial cleansers, to which ... their small size and buoyancy, they may readily ... a global contaminant in the world,s oceans, but ...
(Date:9/18/2014)... in DNA, tiny strands of nucleic acid that contain ... this genetic data, our DNA is copied into RNA ... perform tasks in our cells. , Several years ... Unlike all other known RNAs, this molecule is circular, ... abundant, little has been known about how they are ...
Breaking Biology News(10 mins):Tree rings and arroyos 2Tree rings and arroyos 3Tree rings and arroyos 4Tree rings and arroyos 5Tree rings and arroyos 6Tree rings and arroyos 7Microplastic pollution discovered in St. Lawrence River sediments 2Scientists find how mysterious 'circular RNA' is formed, claim muscular dystrophy link 2
... In the last decade, a new strain of MRSA has ... risk of contracting the dangerous bacterial infection. This particular strain ... of genes not shared by any other strains, though it ... to survive and persist in the community. Now, research ...
... The rate of chemical processes in cells is dictated by ... given reaction. Using a versatile method developed at the Institute ... Warsaw, researchers were able to predict for the first time ... . The achievement is important not only for biologists and ...
... the original Otom inhabitants of Xaltocan, the capital of ... long wondered whether they assimilated with the Aztecs or ... research from The University of Texas at Austin, Wichita ... lie in DNA. Following this line of evidence, the ...
Cached Biology News:UNC study may lead to treatments that are effective against all MRSA strains 2Biologistics: How fast do chemical trains move in living cells? 2Biologistics: How fast do chemical trains move in living cells? 3Aztec conquest altered genetics among early Mexico inhabitants, new DNA study shows 2